Amphiphilic block copolymers promote gene delivery in vivo to pathological skeletal muscles

被引:43
作者
Richard, P [1 ]
Bossard, F [1 ]
Desigaux, L [1 ]
Lanctin, C [1 ]
Bello-Roufai, M [1 ]
Pitard, B [1 ]
机构
[1] Fac Med, INSERM, U533, Inst Thorax, F-44000 Nantes, France
关键词
D O I
10.1089/hum.2005.16.1318
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We reported that amphiphilic block copolymers hold promise as nonviral vectors for the delivery of plasmid DNA, ranging from 4.7 to 6.2 kb, to healthy muscle for the production of local or secreted proteins. To evaluate the efficiency of these vectors to deliver large plasmid DNA molecules to pathological muscles, plasmid DNAs of various lengths were complexed with Lutrol or poloxamine 304 and injected intramuscularly into dystrophic muscles. Lutrol - DNA and poloxamine 304 - DNA complexes promoted gene transfer into muscles of the naturally occurring mouse model for DMD (mdx) in a dose- and plasmid DNA size- dependent manner. For small plasmid DNAs encoding reporter genes, this improvement over naked DNA was smaller in mdx than in the wild- type control strain. By contrast, Lutrol enabled us to deliver the large plasmid (16.1 kb) encoding the rod- deleted dystrophin in mdx mouse muscle, whereas the same amount of naked DNA did not lead to dystrophin expression, under the same experimental conditions. Lutrol- treated mdx mice showed the production of dystrophin in large numbers of muscle fibers. More importantly, we also found that expressing dystrophin with Lutrol led to restoration of the dystrophin- associated protein complex. Thus, we conclude that block copolymers constitute a novel class of vectors for the delivery of large plasmid DNA not only to healthy muscles but also to pathological muscle tissues.
引用
收藏
页码:1318 / 1324
页数:7
相关论文
共 10 条
[1]   Electroporation-facilitated delivery of plasmid DNA in skeletal muscle: Plasmid dependence of muscle damage and effect of poloxamer 188 [J].
Hartikka, J ;
Sukhu, I ;
Buchner, C ;
Hazard, D ;
Bozoukova, V ;
Margalith, M ;
Nishioka, WK ;
Wheeler, CJ ;
Manthorpe, M ;
Sawdey, M .
MOLECULAR THERAPY, 2001, 4 (05) :407-415
[2]   Evaluation of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) gels as a release vehicle for percutaneous fentanyl [J].
Liaw, J ;
Lin, YC .
JOURNAL OF CONTROLLED RELEASE, 2000, 68 (02) :273-282
[3]   Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles [J].
Lu, QL ;
Rabinowitz, A ;
Chen, YC ;
Yokota, T ;
Yin, HF ;
Alter, J ;
Jadoon, A ;
Bou-Gharios, G ;
Partridge, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (01) :198-203
[4]   Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse [J].
Lu, QL ;
Mann, CJ ;
Lou, F ;
Bou-Gharios, G ;
Morris, GE ;
Xue, SA ;
Fletcher, S ;
Partridge, TA ;
Wilton, SD .
NATURE MEDICINE, 2003, 9 (08) :1009-1014
[5]   Direct observation of poloxamer 188 insertion into lipid monolayers [J].
Maskarinec, SA ;
Hannig, J ;
Lee, RC ;
Lee, KYC .
BIOPHYSICAL JOURNAL, 2002, 82 (03) :1453-1459
[6]   Negatively charged self-assembling DNA/poloxamine nanospheres for in vivo gene transfer -: art. no. e159 [J].
Pitard, B ;
Bello-Roufaï, M ;
Lambert, O ;
Richard, P ;
Desigaux, L ;
Fernandes, S ;
Lanctin, C ;
Pollard, H ;
Zeghal, M ;
Rescan, PY ;
Escande, D .
NUCLEIC ACIDS RESEARCH, 2004, 32 (20) :e159
[7]   A nonionic amphiphile agent promotes gene delivery in vivo to skeletal and cardiac muscles [J].
Pitard, B ;
Pollard, H ;
Agbulut, O ;
Lambert, O ;
Vilquin, JT ;
Cherel, Y ;
Abadie, J ;
Samuel, JL ;
Rigaud, JL ;
Menoret, S ;
Anegon, I ;
Escande, D .
HUMAN GENE THERAPY, 2002, 13 (14) :1767-1775
[8]   Inducible production of erythropoietin using intramuscular injection of block copolymer/DNA formulation [J].
Richard, P ;
Pollard, H ;
Lanctin, C ;
Bello-Roufaï, M ;
Désigaux, L ;
Escande, D ;
Pitard, B .
JOURNAL OF GENE MEDICINE, 2005, 7 (01) :80-86
[9]   Phase I study of dystrophin Duchenne/Becker plasmid-based gene therapy in muscular dystrophy [J].
Romero, NB ;
Braun, S ;
Benveniste, O ;
Leturcq, F ;
Hogrel, JY ;
Morris, GE ;
Barois, A ;
Eymard, B ;
Payan, C ;
Ortega, V ;
Boch, AL ;
Lejean, L ;
Thioudellet, C ;
Mourot, B ;
Escot, C ;
Choquel, A ;
Recan, D ;
Kaplan, JC ;
Dickson, G ;
Klatzmann, D ;
Molinier-Frenckel, V ;
Guillet, JG ;
Squiban, P ;
Herson, S ;
Fardeau, M .
HUMAN GENE THERAPY, 2004, 15 (11) :1065-1076
[10]   Electro transfer of naked DNA in the skeletal muscles of animal models of muscular dystrophies [J].
Vilquin, JT ;
Kennel, PF ;
Paturneau-Jouas, M ;
Chapdelaine, P ;
Boissel, N ;
Delaère, P ;
Tremblay, JP ;
Scherman, D ;
Fiszman, MY ;
Schwartz, K .
GENE THERAPY, 2001, 8 (14) :1097-1107